New Hepatitis B Drug May Offer 'Functional Cure' for Some
A new experimental drug for hepatitis B, bepirovirsen, has shown a 'functional cure' in about 20% of patients, allowing them to stop treatment without virus rebound. The GSK-developed drug is under FDA review.


